TrialScientific reports2026

Atorvastatin reduces recurrent decompensation events in advanced cirrhosis in a randomized placebo-controlled trial.

Khadija A M Glal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.